Menu
Annual · values202620252024202320222021202020192018201720162015
Operating Cash Flow293.22 M USD181.72 M USD181.75 M USD273.06 M USD172.26 M USD108.81 M USD158.22 M USD159.28 M USD220.35 M USD159.74 M USD121.86 M USD127.18 M USD
Depreciation & Amortization111.72 M USD115.59 M USD97.22 M USD93.31 M USD97.75 M USD84.29 M USD110.29 M USD109.42 M USD89.25 M USD89.73 M USD89.91 M USD86.05 M USD
Stock-Based Compensation33.83 M USD29.64 M USD28.33 M USD25.58 M USD24.36 M USD25.52 M USD20.45 M USD17.19 M USD13.03 M USD9.15 M USD6.95 M USD14.10 M USD
Capital Expenditures32.78 M USD39.28 M USD66.30 M USD110.19 M USD96.51 M USD37.04 M USD48.76 M USD118.96 M USD74.80 M USD76.14 M USD102.41 M USD122.22 M USD
Cash Flow from Investing-179.55 M USD-161.90 M USD-322.39 M USD-143.79 M USD-86.34 M USD-425.44 M USD-57.18 M USD-116.15 M USD-63.04 M USD-73.31 M USD-104.77 M USD-121.77 M USD
Cash Flow from Financing-178.46 M USD108.82 M USD38.16 M USD-100.36 M USD-15.75 M USD367.45 M USD-131.21 M USD-50.63 M USD-120.64 M USD-60.41 M USD-62.62 M USD-33.16 M USD
Dividends Paid
Stock Buybacks175.00 M USD225.00 M USD0 USD75.00 M USD0 USD0 USD175.00 M USD160.00 M USD100.00 M USD0 USD60.98 M USD39.03 M USD
Free Cash Flow260.44 M USD142.45 M USD115.45 M USD162.87 M USD75.75 M USD71.77 M USD109.46 M USD40.32 M USD145.55 M USD83.60 M USD19.46 M USD4.96 M USD

Haemonetics Corporation is a global healthcare company dedicated to providing innovative blood management solutions for organizations around the world. The company plays a crucial role in the healthcare industry by offering devices and services that aim to improve the quality, efficiency, and safety of blood supply. Haemonetics is known for its comprehensive portfolio, which includes blood collection and processing systems, plasma collection devices, and software solutions for blood centers and hospitals. The core focus of Haemonetics' offerings lies in enhancing blood donor and patient care, optimizing blood banks' operations, and ensuring the safety and availability of blood and blood components. It serves a wide array of sectors, including hospitals, blood centers, and plasma collection centers, facilitating the global demand for transfusion medicine. With its headquarters in Boston, Massachusetts, Haemonetics continues to influence the landscape of healthcare through its commitment to innovation and its significant contributions to enhancing blood management practices. By catering to a vital segment of the healthcare system, Haemonetics Corporation supports the delivery of essential medical treatments and therapies worldwide.